期刊文献+

容积旋转调强计划遮挡技术应用于早期鼻腔NK/T细胞淋巴瘤的剂量学研究

Avoidance technique applied in volumetric modulated arc therapy for early-stage nasal natural killer/T-cell lymphoma:a dosimetric study
下载PDF
导出
摘要 目的:比较3种容积旋转调强计划(VMAT)的剂量学差异,探讨VMAT遮挡技术对早期鼻腔NK/T细胞淋巴瘤的剂量学影响。方法:选取20例早期鼻腔NK/T细胞淋巴瘤患者,分别设计无晶体遮挡(VMAT-OFF)计划、晶体半遮挡(VMAT-E)计划和晶体全遮挡(VMAT-E&E)计划,评估3组计划的计划靶区体积(PTV)和危及器官(OARs)剂量学参数,评估机器跳数(MU)和SCIMOCA通过率(3%/2 mm)。结果:3种计划的靶区剂量分布均能满足临床要求,PTV的D_(2%)、D_(98%)、V_(95%)、均匀性指数、适形度指数均无统计学差异;在MU方面,VMAT-OFF<VMAT-E<VMAT-E&E(P<0.05);在OARs晶体(D_(max)、D_(mean))方面,VMAT-E&E<VMAT-OFF(P<0.05),VMAT-E&E<VMAT-E(P<0.05),D_(max)和D_(mean)均无统计学差异;靶区、晶体和计划的SCIMOCA通过率(3%/2 mm)都高于95%且无统计学差异。结论:VMAT-E&E计划的MU较高,但在保护晶体方面更有优势。 Objective To compare the dosimetric differences among 3 different volumetric modulated arc therapy(VMAT)plans,and to explore the dosimetric effects of VMAT avoidance technique on early-stage nasal natural killer/T-cell lymphoma.Methods Twenty patients with early-stage nasal natural killer/T-cell lymphoma were enrolled in the study,and 3 kinds of plans,namely no lens avoidance plan(VMAT-OFF),lens half-avoidance(VMAT-E)and lens avoidance plan(VMAT-E&E),were designed for each patients.The dosimetric parameters of planning target volume(PTV)and organs-atrisk were compared among 3 kinds of groups,and meanwhile,monitor units(MU)and SCIMOCA passing rate(3%/2 mm)were evaluated.Results The target dose distribution in 3 kinds of plans all met the prescribed dose requirements.There was no statistically difference in the D_(2%),D_(98%),V_(95%),homogeneity index and conformity index of PTV.MU was highest in VMATE&E,followed by VMAT-E and VMAT-OFF(P<0.05).The D_(max) and D_(mean) to lens in VMAT-E&E were lower than those in VMAT-OFF(P<0.05)and VMAT-E(P<0.05),and no statistically difference was found in the D_(max) and D_(mean) to other OAR.The SCIMOCA passing rate(3%/2 mm)of PTV,lens and plans were all higher than 95%,without statistical differences.Conclusion Although VMAT-E&E has relatively higher MU,it has more advantages in lens sparing.
作者 徐婷婷 靳富 杨含 XU Tingting;JIN Fu;YANG Han(Department of Radiology,Fengdu People's Hospital of Chongqing,Chongqing 408299,China;Department of Radiation Oncology,Chongqing University Cancer Hospital/Chongqing Cancer Institute Chongqing Cancer Hospital,Chongqing 400030,China)
出处 《中国医学物理学杂志》 CSCD 2022年第2期146-151,共6页 Chinese Journal of Medical Physics
基金 国家自然科学基金(11575038)。
关键词 NK/T细胞 淋巴瘤 容积旋转调强 晶体 遮挡 放射治疗 natural killer/T-cell lymphoma volumetric modulated arc therapy lens avoidance radiotherapy
  • 相关文献

参考文献10

二级参考文献66

  • 1张矛,金海国,卜明伟,孙宝胜,孙术全,苏清秀,李玉平.脑胶质瘤术后VMAT与IMRT放疗技术间比较[J].中国医学物理学杂志,2011,28(6):2959-2963. 被引量:30
  • 2张矛,田琦.106例放射性肺炎相关因素分析[J].实用肿瘤学杂志,2005,19(4):290-291. 被引量:2
  • 3Yang QP, Zhang WY, Yu JB, et al. Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a Single Institution [J/OL]. Diagn Pathol, 2011,6:77 [2014-03-19]. http://www, ncbi. nlm. nih. gov/ pmc/artieles/PMC3179701/.
  • 4Sun J, Yang Q, Lu Z, et al. Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification [J]. Am J Clin Pathol,2012 ,138 :429- 434.
  • 5Li YX, Coucke PA, Li JY, et al. Primary non-Hodgkin' s lymphoma of the nasal cavity : prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy [J]. Cancer, 1998,83:449-456.
  • 6Li YX, Fang H, IAu QF, et al. Clinical features and treatment outcome of nasal-type NK,/T-eell lymphoma of Waldeyer ring [ J]. Blood ,2008,112:3057-3064.
  • 7Li YX, Liu QF, Fang H, et al. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma [ J]. Clin Cancer Res ,2009,15:2905-2912.
  • 8Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cen lymphoma:a study of 136 cases from the international peripheral T- cell lymphoma project [ J]. Blood,2009,113:3931-3937.
  • 9Li YX, Yao B, Jin J, et al. Radiotherapy as primary treatment for stage I E and Ⅱ] E nasal natural killer/T-cell lymphoma [ J]. J Clin Onco1,2006,24 : 181-189.
  • 10Vazquez A, Khan MN, Blake DM, et al. Extranodal natural killer/T-Cell lymphoma : a population-based comparison of sinonasal and extranasal disease [J]. Laryngoscope,2014, 124: 888-895.

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部